About
Speclipse, Inc., is the medical device developer of the world's first cancer diagnostic solution based on laser-induced plasma spectroscopy (LIPS) and artificial intelligence (AI) technology. Our core technology, Spectra-Scope®, embodies a real-time, non-invasive, in-vivo diagnosis of skin cancers without compromising efficacy and accuracy while preventing unnecessary biopsies. We are committed to providing innovative medical technology to assist in challenging diagnosis cases—and it is our mission to continue to improve our technology so physicians can spend more time focusing on their patients and making accurate diagnoses.
Technologies
Gmail
Google Apps
Google Cloud Hosting
Sisense
Domo
Keywords
laser treatment
medical device development
laserinduced plasma spectroscopy
cancer diagnostic technology
skin cancer prevention
skin cancer screening
artificial intelligence
medical technology
skin cancer awareness
dermatology
information technology & services
Company Information
-
Employees 9
-
Founded 2015
-
Total Funding $7700000
Location
310 De Guigne Dr, Sunnyvale, California, United States, 94085-3906
